Timothy M. Wright

Visual Field Outcomes from the Multicenter, Randomized Controlled Laser in Glaucoma and Ocular Hypertension Trial (LiGHT).

A slightly larger proportion of ocular hypertensive and glaucoma patients treated first with medical therapy underwent rapid VF progression compared with those treated first with SLT.

Prevalence of Glaucoma in Europe and Projections to 2050: Findings from the European Eye Epidemiology Consortium.

The current and future burden of glaucoma in Europe may be substantially higher than previously estimated, with a considerable proportion of disease in the general population remaining undetected.

Estimating the Distribution of True Rates of Visual Field Progression in Glaucoma.

The distribution of "true" RoPs can be estimated with an exGaussian-LMM, improving model accuracy.

Diagnostic Accuracy of Spectral-Domain OCT Circumpapillary, Optic Nerve Head, and Macular Parameters in the Detection of Perimetric Glaucoma.

Macular and optic nerve head OCT parameters were not better than cRNFL measurements to diagnose glaucoma in this population.

Six-Year Rate of Visual Field Progression in the Laser in Glaucoma and Ocular Hypertension Trial.

First-line SLT was more effective than drops at preserving VF.

Validating and Updating the OHTS-EGPS Model Predicting 5-year Glaucoma Risk among Ocular Hypertension Patients Using Electronic Records.

We performed an external validation of the OHTS-EGPS model in a large English population.

Author Response: The Distribution of True Visual Field Progression Rates in Glaucoma.